Safety Results of a Multi-Institutional Phase 1 Clinical Trial of Afatinib in Combination with Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Margalit, D. N. [1 ,2 ]
Haddad, R. I. [2 ]
Tishler, R. B. [1 ,2 ]
Chau, N. [3 ]
Schoenfeld, J. D. [1 ,2 ]
Bakst, R. L. [4 ]
Misiukiewicz, K. [4 ]
Goguen, L. [2 ,5 ]
Annino, D. [2 ,5 ]
Mchugh, P. [6 ]
Bacay, A.
Rath, L. [4 ]
Groden, P. [6 ]
Catalano, P. S. [7 ]
Rabinowits, G. [3 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Otolaryngol, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
95
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Final Safety Results of a Phase 1 Clinical Trial of Afatinib in Combination With Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck
    Margalit, D. N.
    Haddad, R. I.
    Tishler, R. B.
    Chau, N.
    Schoenfeld, J. D.
    Bakst, R. L.
    Misiukiewicz, K.
    Goguen, L.
    Annino, D.
    Mchugh, P.
    Bacay, A.
    Groden, P.
    Catalano, P. S.
    Rabinowits, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1325 - 1325
  • [2] A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck
    Margalit, Danielle N.
    Haddad, Robert I.
    Tishler, Roy B.
    Chau, Nicole G.
    Schoenfeld, Jonathan D.
    Bakst, Richard L.
    Misiukiewicz, Krzysztof J.
    Gupta, Vishal
    Posner, Marshall
    Hanna, Glenn J.
    Mahmood, Umair
    Rawal, Bhupendra
    Catalano, Paul J.
    Rath, Lynda
    Bacay, Alyssa
    McHugh, Patricia
    Rabinowits, Guilherme
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : 132 - 139
  • [3] A phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients
    Willey, Christopher D.
    Murphy, Barbara A.
    Netterville, James L.
    Burkey, Brian B.
    Shyr, Yu
    Shakhtour, Bashar
    Kish, Bonnie
    Raben, David
    Chen, Changhu
    Song, John I.
    Kane, Madeleine A.
    Cmelak, Anthony J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1323 - 1331
  • [4] Postoperative Reduced Dose of Cisplatin Concomitant With Radiation Therapy in High-Risk Head and Neck Squamous Cell Carcinoma
    Franchin, Giovanni
    Minatel, Emilio
    Politi, Doriano
    Gobitti, Carlo
    Talamini, Renato
    Vaccher, Emanuela
    Savignano, Maria Gabriella
    Trovo, Marco
    Sulfaro, Sandro
    Barzan, Luigi
    CANCER, 2009, 115 (11) : 2464 - 2471
  • [5] Postoperative radiotherapy for high-risk head and neck squamous cell carcinoma
    Hamamoto, Y.
    Tsuruoka, S.
    Takata, N.
    Ishikawa, H.
    Nagasaki, K.
    Mochizuki, T.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S55 - S55
  • [6] Postoperative Chemoradiation in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Bhatia, Aarti K.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (13) : 1269 - +
  • [7] Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma
    Porceddu, SV
    Campbell, B
    Rischin, D
    Corry, J
    Weih, L
    Guerrieri, M
    Grossi, M
    Peters, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 365 - 373
  • [8] Early results of a phase II multi-institutional trial of chemoradiation (CR) using weekly docetaxel (Doc) and erythropoetin (Epo) for high-risk postoperative head and neck cancer (HRPHNC) patients.
    Cmelak, AJ
    Murphy, BA
    Raben, D
    Kane, M
    Weng, E
    Burkey, B
    Kish, B
    Netterville, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 501S - 501S
  • [9] Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma
    Chera, Bhishamjit S.
    Sheth, Siddharth H.
    Patel, Shetal A.
    Goldin, Dan
    Douglas, Kathe E.
    Green, Rebecca L.
    Shen, Colette J.
    Gupta, Gaorav P.
    Moore, Dominic T.
    Grilley Olson, Juneko E.
    Weiss, Jared M.
    CANCER, 2021, 127 (23) : 4447 - 4454
  • [10] Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chung, Christine H.
    Li, Jiannong
    Steuer, Conor E.
    Bhateja, Priyanka
    Johnson, Matthew
    Masannat, Jude
    Poole, Maria I.
    Song, Feifei
    Hernandez-Prera, Juan C.
    Molina, Helen
    Wenig, Bruce M.
    Kumar, Sunil
    Kuperwasser, Charlotte
    Stephens, Philip J.
    Farinhas, Joaquim M.
    Shin, Dong M.
    Kish, Julie A.
    Muzaffar, Jameel
    Kirtane, Kedar
    Rocco, James W.
    Schell, Michael J.
    Saba, Nabil F.
    Bonomi, Marcelo
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2329 - 2338
12345